Kurome Therapeutics
Mikkael A. Sekeres as Chief, Division of Hematology, University of Miami Miller School of Medicine–Sylvester Comprehensive Cancer Center. He is also the former Chair of the Oncologic Drugs Advisory Committee of the F.D.A.
This person is not in the org chart
This person is not in any offices
Kurome Therapeutics
Kurome Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.